Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#1767 most reported symptom for this vaccine
Mucosal dryness has been reported 8 times in association with Influenza, Seasonal (Fluvirin) vaccination in VAERS. This represents 0.0% of all 119,695 reports for this vaccine.
Among these reports, 3 mentioned death (37.50%) and 3 involved hospitalization (37.5%).
Mucosal dryness is the #1767 most frequently reported symptom for Influenza, Seasonal (Fluvirin) out of 3021 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 8 reports of Mucosal dryness after Influenza, Seasonal (Fluvirin) vaccination may seem alarming, but context is critical. With 119,695 total reports for this vaccine (representing many millions of doses), Mucosal dryness appears in only 0.0% of reports.
The 37.50% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.